Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BMGL
Basel Medical Group
$4.78
+1.1%
$0.00
$3.63
$5.50
$88.22MN/A137,338 shs15,258 shs
Burning Rock Biotech Limited stock logo
BNR
Burning Rock Biotech
$2.33
-2.9%
$3.90
$2.18
$8.99
$23.87M0.7219,092 shs80,203 shs
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
$3.88
-1.3%
$3.80
$1.85
$6.30
$95.56M-0.0580,854 shs105,423 shs
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
$2.17
+1.4%
$2.21
$1.86
$4.17
$93.51M0.65192,797 shs66,615 shs
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BMGL
Basel Medical Group
+0.21%+16.22%+472,999,900.00%+472,999,900.00%+472,999,900.00%
Burning Rock Biotech Limited stock logo
BNR
Burning Rock Biotech
+3.45%-16.38%-32.75%-62.96%-68.83%
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
+5.36%+4.74%+8.26%-10.07%+99.49%
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
0.00%0.00%+8.63%-27.95%-47.42%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
BMGL
Basel Medical Group
N/AN/AN/AN/AN/AN/AN/AN/A
Burning Rock Biotech Limited stock logo
BNR
Burning Rock Biotech
1.761 of 5 stars
0.05.00.00.03.31.70.6
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
0.6635 of 5 stars
0.05.00.00.00.90.00.6
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
1.6031 of 5 stars
3.52.00.00.00.01.70.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
BMGL
Basel Medical Group
0.00
N/AN/AN/A
Burning Rock Biotech Limited stock logo
BNR
Burning Rock Biotech
0.00
N/AN/AN/A
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
4.00
Strong BuyN/AN/A
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
3.00
Buy$6.25188.02% Upside

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
BMGL
Basel Medical Group
$10.05M8.78N/AN/AN/A
Burning Rock Biotech Limited stock logo
BNR
Burning Rock Biotech
$515.82M0.05N/AN/A$10.56 per share0.22
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
$4.01M23.82N/AN/A($0.30) per share-12.93
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
$244.72M0.38$0.85 per share2.56$2.47 per share0.88
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
BMGL
Basel Medical Group
N/AN/A0.00N/AN/AN/AN/AN/A
Burning Rock Biotech Limited stock logo
BNR
Burning Rock Biotech
-$92.07M-$1.88N/AN/A-83.50%-60.68%-42.30%5/26/2025 (Estimated)
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
-$10.04MN/A0.00N/AN/AN/AN/AN/A5/9/2025 (Estimated)
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
-$6.76M-$0.17N/AN/AN/A-2.90%-6.70%-2.94%5/12/2025 (Estimated)

Latest BNR, EUDA, QIPT, and BMGL Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/12/2025Q2 2025
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
$0.02N/AN/AN/A$88.29 millionN/A
3/25/2025Q4 2024
Burning Rock Biotech Limited stock logo
BNR
Burning Rock Biotech
-$1.3970-$1.08+$0.3170-$1.08N/A$17.27 million
2/10/2025Q1 2025
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
N/A-$0.03N/A-$0.03N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
BMGL
Basel Medical Group
N/AN/AN/AN/AN/A
Burning Rock Biotech Limited stock logo
BNR
Burning Rock Biotech
N/AN/AN/AN/AN/A
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
N/AN/AN/AN/AN/A
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
BMGL
Basel Medical Group
N/AN/AN/A
Burning Rock Biotech Limited stock logo
BNR
Burning Rock Biotech
N/A
3.04
2.78
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
N/A
0.13
N/A
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
0.74
1.22
0.87

Institutional Ownership

CompanyInstitutional Ownership
BMGL
Basel Medical Group
N/A
Burning Rock Biotech Limited stock logo
BNR
Burning Rock Biotech
30.03%
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
4.35%
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
42.85%

Insider Ownership

CompanyInsider Ownership
BMGL
Basel Medical Group
N/A
Burning Rock Biotech Limited stock logo
BNR
Burning Rock Biotech
30.30%
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
N/A
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
13.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
BMGL
Basel Medical Group
3618.46 millionN/AN/A
Burning Rock Biotech Limited stock logo
BNR
Burning Rock Biotech
1,39010.24 million7.14 millionNot Optionable
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
224.63 millionN/ANot Optionable
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
80043.09 million37.32 millionOptionable

Recent News About These Companies

Quipt Home Medical (QIPT) Receives a Buy from Stifel Nicolaus
Quipt Home Medical Corp. (QIPT): A Bull Case Theory
Quipt Home Medical Corp. (QIPT): A Bull Case Theory
Quipt Home Medical price target lowered to C$6.70 from C$7 at Stifel

New MarketBeat Followers Over Time

Media Sentiment Over Time

Basel Medical Group NASDAQ:BMGL

$4.78 +0.05 (+1.06%)
As of 03:59 PM Eastern

OUR MISSION Basel Medical transcends the role of a conventional healthcare provider. We strive for excellence in medical services and aim to serve as a beacon of hope for patients across Singapore and Southeast Asia. Our mission encompasses the four following commitments: Patient–Centered Care. We prioritize our patient’s wellbeing above all else. Innovation. We strive for excellence through innovation and expertise. Global Accessibility. We believe that quality healthcare should be universally available. Continuous Improvement. We constantly improve our services to meet evolving patient needs. With over 20 years of medical services experience, Basel Medical’s journey began with a simple commitment – to restore healthy and active lifestyles, one at a time. Today, that commitment has transformed into a vision for innovation, growth and far-reaching impact. We rely on an experienced group of medical practitioners to provide a wide spectrum of general and subspecialized orthopedic, trauma, sports medicine and neurosurgical services such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery, minimally invasive orthopedic procedures and other complex neurosurgical procedures. We operate our two clinics at Gleneagles Medical Centre in Singapore and currently have five medical practitioners practicing with Basel Medical (together with its subsidiaries, the “Group”), comprising four orthopedic specialists and one neurosurgery specialist. The services provided by our clinics include, but are not limited to, consultation, medical diagnosis and medical or surgical treatments for orthopedic, trauma, sports medicine and neurological conditions and our clinics are equipped with the facilities needed to perform a variety of procedures on site and minor surgical services, while more complex surgical procedures are performed at operating theaters of other hospitals with such facilities. Our Group has a patient-oriented philosophy of providing personalized, quality and integrated medical care. We aim to be a one-stop integrated healthcare provider for all musculoskeletal-related medical care, including post-surgery rehabilitation services such as physiotherapy as well as other ancillary services such as pain management. Within the next 12 to 18 months, we intend to actively seek acquisition and collaboration partners in Singapore and Malaysia. Our acquisition and collaboration targets include general practitioner (GP) clinics and specialist clinics that complement our orthopedic services, particularly those focused on the musculoskeletal system, aging treatments, physiotherapy and occupational therapists. Our goal is to become an internationally known medical services provider in the Southeast Asian market, with a presence in at least four Southeast Asia countries (potentially covering Singapore, Malaysia, Indonesia and Thailand) within the next three years. As of the date of this prospectus, we have not identified such targets. Basel Medical was incorporated in the BVI on August 10, 2023 with registered number 2129740 as a BVI business company with liability limited by shares. Our BVI registered office is located at Kingston Chambers, PO Box 173, Road Town, Tortola, British Virgin Islands VG1110. Our principal executive offices are located in Singapore at 6 Napier Road, Unit #02-10/11 Gleneagles Medical Centre, Singapore. Our agent for service of process in the United States is Puglisi & Associates at 850 Library Avenue, Suite 204, Newark, Delaware.

Burning Rock Biotech stock logo

Burning Rock Biotech NASDAQ:BNR

$2.33 -0.07 (-2.92%)
As of 01:55 PM Eastern

Burning Rock Biotech Limited primarily develops and commercializes cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based tissue and liquid biopsy cancer therapy selection and prognosis prediction tests for various range of cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, colorectal cancer, ovarian cancer, pancreatic cancer, and bladder cancer using tissue and liquid biopsy samples. Its principal products include OncoCompass IO, a corresponding test for liquid biopsy samples; OncoScreen IO, a pan-cancer test for tissue samples; and OncoCompass Target, a ctDNA liquid biopsy-based test for NSCLC. In addition, the company provides ColonCore for assessing microsatellite loci related to MSI status and detecting mutations in genes associated with gastrointestinal cancers; and brPROPHET, a pre-operative ctDNA detection and post-operative MRD calling for relapsed patients. Further, it has development and commercialization agreement with Myriad Genetics, Inc. to in-license Myriad myChoice tumor testing in China; licensing agreement with Oncocyte Corporation to in-license DetermaRx, a risk stratification test for early stage lung cancer patients in China; and collaborations on clinical trials and research studies with AstraZeneca, Bayer, Johnson & Johnson, CStone, BeiGene, Abbisko Therapeutics, and IMPACT Therapeutics and Merck KGaA. Additionally, the company offers OncoMaster, an automatic NGS data analysis and report interpretation machine for in-hospital model. Burning Rock Biotech Limited was incorporated in 2014 and is headquartered in Guangzhou, China.

EUDA Health stock logo

EUDA Health NASDAQ:EUDA

$3.88 -0.05 (-1.27%)
As of 03:57 PM Eastern

EUDA Health Holdings Limited operates as a healthcare specialty company. The company operates through two segments, Medical Services and Property Management Services. It offers a range of specialty care services to patients; and operates medical facility general practice clinic that provides holistic care for various illnesses. The company is also involved in the property management that services shopping malls, business office building, or residential apartments. EUDA Health Holdings Limited is headquartered in Singapore.

Quipt Home Medical stock logo

Quipt Home Medical NASDAQ:QIPT

$2.17 +0.03 (+1.40%)
As of 03:59 PM Eastern

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment. It offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep apnea, reduced mobility, and other chronic health conditions. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. is headquartered in Wilder, Kentucky.